Glucagonoma syndrome.
Bloom SR, Polak JM.
Am J Med. 1987 May 29;82(5B):25-36. doi: 10.1016/0002-9343(87)90424-4.
Glucagonoma and Glucagonoma Syndrome: An Updated Review.
Anelli S, Mazzilli R, Zamponi V, Giorgini B, Golisano B, Mancini C, Russo F, Panzuto F, Faggiano A.
Clin Endocrinol (Oxf). 2025 Oct;103(4):417-426. doi: 10.1111/cen.15300. Epub 2025 Jul 4.
Glucagonoma syndrome: a review and update on treatment.
John AM, Schwartz RA.
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2016-2022. doi: 10.1111/jdv.13752. Epub 2016 Jul 16.
[Glucagonoma syndrome].
Tellechea O, Baptista AP.
Acta Med Port. 1988 Mar-Apr;1(2):149-52.
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad V, Ruszniewski P, Thirlwell C, Vullierme MP, Welin S, Bartsch DK.
J Neuroendocrinol. 2023 Aug;35(8):e13318. doi: 10.1111/jne.13318. Epub 2023 Aug 14.
The glucagonoma syndrome.
Wynick D, Hammond PJ, Bloom SR.
Clin Dermatol. 1993 Jan-Mar;11(1):93-7. doi: 10.1016/0738-081x(93)90103-j.
Glucagonoma syndrome.
van Hecke E, Geerts ML, Kint A, Debersaques J, Naeyaert JM.
Curr Probl Dermatol. 1991;20:24-33. doi: 10.1159/000420005.
Glucagonoma tumors and syndrome.
Montenegro-Rodas F, Samaan NA.
Curr Probl Cancer. 1981 Dec;6(6):1-54. doi: 10.1016/s0147-0272(81)80014-1.
[Glucagonoma syndrome].
Levitskaia ZI, Balabolkin MI, Gordina AA.
Ter Arkh. 1987;59(11):137-42.
[Glucagonoma syndrome].
Antonov AV.
Probl Endokrinol (Mosk). 1987 Jan-Feb;33(1):70-8.
